Polomar Health Services, Inc. Update: Merger Hurdles Cleared

The merger between Polomar Health Services, Inc. (Polomar) and Altanine, Inc. is entering its final stage. On May 11, 2026, both companies signed a "Consent and Waiver" letter. This document changes the original merger agreement by removing five specific requirements that previously had to be met before the deal could close.

Here is a simple breakdown of what this means for you.

1. What exactly changed?

Think of the original merger agreement as a checklist of "must-haves." By signing this waiver, the companies have crossed off five major items. They are no longer required to:

• Hit a $10 stock price: They no longer need to perform a reverse stock split or ensure the share price reaches $10 before closing.
• Secure a $25 million credit line: The requirement to finalize this loan before the merger is gone.
• Get SEC approval for the S-4 statement: The companies will proceed without waiting for the SEC to declare the registration statement effective.
• Get Nasdaq approval: They no longer need formal approval to list the combined company’s shares on the Nasdaq before the deal closes.
• Complete "Concurrent Financing": The companies dropped the requirement to raise extra cash to strengthen the combined company’s balance sheet.

2. Why does this matter?

The companies are choosing speed over the original financial and regulatory safeguards. By removing these hurdles, they aim to close the deal as quickly as possible.

For you, this changes the risk. The original "safety nets"—like the $10 price target and the $25 million credit line—were meant to ensure the new company had enough cash and institutional backing. Removing these requirements means the new company will likely have less cash on hand and lacks the initial regulatory stamp of approval from the Nasdaq.

3. What does this mean for you?

• For Investors: The deal is now more likely to close soon, but the risk is higher. Without the credit line or the stock price floor, the company may be more sensitive to market swings and could face cash shortages after the merger.
• For the Business: This waiver acts as a legal release. The companies agree that failing to meet these five goals is no longer a breach of contract. This clears the path to finalize the merger without these specific issues stopping the deal.

4. What’s next?

The companies are now focused on the "Effective Time," when the two businesses officially become one. With these five conditions removed, they will focus on the remaining requirements.

The company didn't provide much detail about the specific timeline for the final closing, but they must still provide audited financial statements before the deal is officially done. Keep a close eye on these filings, as they will be the best indicator of the new company’s actual financial health.

Bottom line: The path is clear for a quick merger. However, removing these financial and regulatory guardrails suggests a leaner, riskier transition. If you are considering an investment, weigh the potential for a quick deal against the reality that the new entity will be operating with less capital and fewer regulatory protections than originally planned. Proceed with caution and watch how the market reacts to these changes.